Inga Peters
Impact in
-
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Chronic Obstructive Pulmonary Disease (COPD) Research
-
- MicroRNA in disease regulation
Papers in
-
- Renal cell carcinoma treatment 21
- Prostate Cancer Diagnosis and Treatment 8
- Prostate Cancer Treatment and Research 8
- Co-authors
- Markus A. KuczykJürgen SerthAxel S. MerseburgerJörg HennenlotterArnulf StenzlHossein TezvalNatalia DubrowinskajaDS Postma
- Journals
- Advances in Therapy (4 papers)World Journal of Urology (4 papers)PLoS ONE (4 papers)Oncology Reports (3 papers)BMC Cancer (3 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Inga Peters
58 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 99
- Pulmonary and Respiratory Medicine 535
- Cancer Research 153
- Molecular Biology 557
- Oncology 115
- Rheumatology 63
Countries citing papers authored by Inga Peters
This map shows the geographic impact of Inga Peters's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inga Peters with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inga Peters more than expected).
Fields of papers citing papers by Inga Peters
This network shows the impact of papers produced by Inga Peters. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inga Peters. The network helps show where Inga Peters may publish in the future.
Co-authors
The 25 scholars most cited alongside Inga Peters, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 8 | |
| 4 | 2023 | 4 | |
| 5 | 2021 | 2 | |
| 6 | 2020 | 10 | |
| 7 | 2020 | 8 | |
| 8 | 2020 | 1 | |
| 9 | 2017 | 8 | |
| 10 | 2016 | 18 | |
| 11 | 2015 | 135 | |
| 12 | 2014 | 41 | |
| 13 | 2014 | 19 | |
| 14 | 2013 | 6 | |
| 15 | 2013 | 3 | |
| 16 | 2013 | 12 | |
| 17 | 2012 | 19 | |
| 18 | 2012 | 27 | |
| 19 | 2011 | 39 | |
| 20 | 2010 | 6 |
About Inga Peters
Inga Peters is a scholar working on Pulmonary and Respiratory Medicine, Behavioral Neuroscience, Rheumatology, Molecular Biology and Cancer Research, having authored 59 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (21 papers), Epigenetics and DNA Methylation (21 papers), Renal and related cancers (19 papers), Bladder and Urothelial Cancer Treatments (9 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Prostate Cancer Treatment and Research (8 papers), Cancer-related gene regulation (6 papers) and Urologic and reproductive health conditions (6 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (535 citations), Cancer Research (153 citations), Molecular Biology (557 citations), Oncology (115 citations) and Rheumatology (63 citations). Inga Peters has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Markus A. Kuczyk, Jürgen Serth, Axel S. Merseburger, Jörg Hennenlotter, Arnulf Stenzl, Hossein Tezval, Natalia Dubrowinskaja, DS Postma, Hj Sluiter and Ralph Scherer. Their work appears in journals such as Advances in Therapy, World Journal of Urology, PLoS ONE, Oncology Reports and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.